Growth Metrics

Vycor Medical (VYCO) Free Cash Flow Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -1.82%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 226.77%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 9.73%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -51.69%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -109.40%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 133.09%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 363.84%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 108.16%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 29.12%
10 Vycor Medical - - 375,153.00 469.47%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 469.47%
Dec 31, 2025 198.30%
Sep 30, 2025 -791.77%
Jun 30, 2025 -45.80%
Mar 31, 2025 -1,526.02%
Dec 31, 2024 -9,566.41%
Sep 30, 2024 170.44%
Jun 30, 2024 507.41%
Mar 31, 2024 -92.34%
Dec 31, 2023 98.80%
Sep 30, 2023 80.61%
Jun 30, 2023 150.34%
Mar 31, 2023 131.25%
Dec 31, 2022 -203.98%
Sep 30, 2022 -11.34%
Jun 30, 2022 -136.00%
Mar 31, 2022 -35.61%
Dec 31, 2021 504.74%
Sep 30, 2021 60.41%
Jun 30, 2021 263.21%
Mar 31, 2021 28.48%
Dec 31, 2020 70.46%
Sep 30, 2020 -4,833.84%
Jun 30, 2020 -311.20%
Mar 31, 2020 -233.16%
Dec 31, 2019 -240.64%
Sep 30, 2019 108.62%
Jun 30, 2019 91.81%
Mar 31, 2019 84.56%
Dec 31, 2018 109.49%
Sep 30, 2018 75.52%
Jun 30, 2018 -507.98%
Mar 31, 2018 49.74%
Dec 31, 2017 -41.82%
Sep 30, 2017 -1,507.45%
Jun 30, 2017 87.41%
Mar 31, 2017 -44.59%
Dec 31, 2016 45.22%
Sep 30, 2016 96.84%
Jun 30, 2016 29.60%
Mar 31, 2016 57.77%
Sep 30, 2015 8.16%
Jun 30, 2015 60.53%
Mar 31, 2015 56.70%
Sep 30, 2014 -117.43%
Jun 30, 2014 -124.92%
Mar 31, 2014 -333.87%
Dec 31, 2013 55.53%
Sep 30, 2013 50.25%
Jun 30, 2013 11.97%
Mar 31, 2013 30.38%
Dec 31, 2012 56.15%
Sep 30, 2012 67.35%
Jun 30, 2012 59.87%
Mar 31, 2012 30.21%
Dec 31, 2011 -100.49%
Sep 30, 2011 -217.53%